Genomics and transcriptomics
tumor
TUMOR
Cell cycle score signatures decreased in all three treatment groups (Additional file Mutational profiling of tumor DNA was performed at baseline in 75 participants (26 participants in the amcenestrant 400 mg arm, 28 participants in the amcenestrant 200 mg arm, and 21 participants in the letrozole arm [Additional file 